FDA Approves New Combo Treatment for Kidney Cancer Patients

A new two-drug combination just got approved to help prevent kidney cancer from coming back after surgery, offering fresh hope to patients at high risk of recurrence.

The treatment combines two different approaches to attack cancer cells and keep them from returning.